knowledge -WSS

knowledge

author：focus 2025-10-01 11:46:56 - browse：2

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Brain worms: The science behind RFK Jr.'s parasitic infection

focus

explore

WSS

Readout Newsletter: Illumina, CRISPR, Regeneron

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Bird flu outbreak in cows is latest avian flu curveball

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Elevance, private equity launch primary care company

Yancopoulos of Regeneron works to expand Dupixent success

focus

knowledge

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Hepatitis C has a cure — but many Americans still lack access to it

Study: People of West African ancestry at greater risk of cardiac amyloidosis

23andMe had bad news about my health. I wish a person had delivered it

Texas board proposes rules on abortion law emergency exemption

Malaria cases in Florida and Texas: Here’s what you need to know

Sanofi strikes deal with Novavax, boosting the vaccine maker

Heart attack and stroke risk calculators need revising

Cancer, immunology, HIV research ensnared in fetal tissue politics

Wikipedia

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Software glitch causes Tandem insulin pump to shutdown, FDA warns

U.K. officials, researchers try to ease path for bespoke genetic treatments

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Readout Newsletter: Illumina, CRISPR, Regeneron

CDC wastewater surveillance dashboard to track bird flu hotspots

focus

focus

explore

entertainment